Innovation | GSK US
WEBWe’re combining the power of genetic and genomic insights into what causes disease, with the speed and scale of artificial intelligence and machine learning (AI/ML) to make better predictions about who a treatment might work for, and why.
Innovation - GSK
WEBWe’re combining the power of genetic and genomic insights into what causes disease, with the speed and scale of artificial intelligence and machine learning (AI/ML) to make better predictions about who a treatment might work for, and why.
WEBAs is also clear from this report, GSK is developing a distinctive role and voice in prevention of disease, offering clear benefits to patients, healthcare systems and wider society. Strategic progress In 2023, we saw further evidence of the success of this transformation. Operationally, GSK is performing better – and crucially more
AI and ML power better predictions for patient impact | GSK
WEBWhen we can pinpoint, prioritise, and pursue the most relevant insights to find better medicines and vaccines faster, and in ways that are more effective, and more predictable. We believe the predictive power of genetics, genomics, and AI holds the key to fundamentally transforming medical discovery for patients, shaping how diseases are both ...
COiMMUNITY grants provide a ground-level boost to vaccine advocacy | GSK …
WEBThree insights for improving adult immunization. To help foster collaboration and glean insights that might help other health advocacy groups who are doing similar work, GSK convened some of the COiMMUNITY grant recipients to share key learnings and challenges that arose from their work to improve adult immunization in 2024.*
GSK and IQVIA launch Vaccine Track, a data trend platform to help ...
WEBAug 8, 2022 · The Vaccine Track platform will enable users to: Identify vaccination trends for adults 19+ in the US across multiple vaccines. Scan immunization claims data nationally and sub-nationally across years. Track trends based on 2019 pre-COVID-19 baseline vaccination uptake.
WEBWhen the pandemic started, GlaxoSmithKline (GSK) Consumer Healthcare set three priorities: caring for its people, ensuring business continuity, and being part of the solution. In July 2020, GSK Consumer Healthcare CEO Brian McNamara spoke with McKinsey senior partner Warren Teichner about the changes the company has made to adapt
GSK plc (GSK) Stock Price, News, Quote & History - Yahoo Finance
WEBFind the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.
GSK's New Drugs and Pipeline Hold the Key to Growth in 2023
WEBJan 3, 2023 · GSK expects its new medicines and vaccines (approved between 2017 and 2021) to contribute around 60% of the new GSK’s (after CHC demerger) sales growth for the period 2022-2026.
GiGi - The GSK Digital Assistant
WEBGiGi is a digital assistant that helps you access GSK's resources, products and services. Learn more about GSK's innovation and commitment to health.
Skip to content